Recombinant Human MED22 Protein，GST

MED22, a subunit of the Mediation complex, plays a crucial role in the regulation of gene expression by serving as a bridge between transcription factors and the RNA polymerase II machinery. As a component of the Mediator complex, which is essential for transcriptional regulation of protein-coding genes, MED22 is involved in various cellular processes, including cell differentiation, proliferation, and response to external stimuli. Recent studies have highlighted MED22's involvement in several biological pathways, linking it to various diseases, including cancer and neurodegenerative disorders. Given its pivotal role in gene regulation, researchers are increasingly interested in understanding the molecular mechanisms underlying MED22 function. This includes the elucidation of its structural properties, interaction with other Mediator components, and the identification of its target genes. Furthermore, the elucidation of MED22's role in specific pathways may provide insights into its potential as a therapeutic target. The production of recombinant MED22 protein is essential for such studies as it allows for in-depth biochemical analyses and functional assays, aiding in the characterization of its role in transcription regulation. Overall, the research on MED22 not only enhances our understanding of transcriptional control but also opens avenues for therapeutic approaches in diseases associated with its dysfunction.